U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C12H15NO3S
Molecular Weight 253.317
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of THIORPHAN

SMILES

OC(=O)CNC(=O)C(CS)CC1=CC=CC=C1

InChI

InChIKey=LJJKNPQAGWVLDQ-UHFFFAOYSA-N
InChI=1S/C12H15NO3S/c14-11(15)7-13-12(16)10(8-17)6-9-4-2-1-3-5-9/h1-5,10,17H,6-8H2,(H,13,16)(H,14,15)

HIDE SMILES / InChI
Ecadotril or sinorphan is the S-enantiomer of racemic acetorphan (racecadotril). It inhibits enkephalinase activity. Ecadotril was studied for the treatment of hypertension and heart failure, however, its development was discontinued.

CNS Activity

Curator's Comment: Ecadotril ((S)-acetorphan) is CNS active in animals when administered parenterally. No human data available.

Originator

Curator's Comment: Roques, B. P., Schwartz, J. C. & Lecomte, J. M., inventors. Derives d'acides amines et leur application therapeutique. Fr. Pat. 8008601, Apr. 17, 1980; Eur. Pat. Appl. EP 38,758; Apr. 14, 1981.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
400 mg 2 times / day multiple, oral (max)
Highest studied dose
Dose: 400 mg, 2 times / day
Route: oral
Route: multiple
Dose: 400 mg, 2 times / day
Sources: Page: p.1142
unhealthy, ADULT
n = 31
Health Status: unhealthy
Condition: Cardiac Failure Congestive
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Population Size: 31
Sources: Page: p.1142
Other AEs: Headache, Dizziness...
Other AEs:
Headache (16%)
Dizziness (grade 1-2, 35%)
Insomnia (6%)
Sources: Page: p.1142
AEs

AEs

AESignificanceDosePopulation
Headache 16%
400 mg 2 times / day multiple, oral (max)
Highest studied dose
Dose: 400 mg, 2 times / day
Route: oral
Route: multiple
Dose: 400 mg, 2 times / day
Sources: Page: p.1142
unhealthy, ADULT
n = 31
Health Status: unhealthy
Condition: Cardiac Failure Congestive
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Population Size: 31
Sources: Page: p.1142
Insomnia 6%
400 mg 2 times / day multiple, oral (max)
Highest studied dose
Dose: 400 mg, 2 times / day
Route: oral
Route: multiple
Dose: 400 mg, 2 times / day
Sources: Page: p.1142
unhealthy, ADULT
n = 31
Health Status: unhealthy
Condition: Cardiac Failure Congestive
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Population Size: 31
Sources: Page: p.1142
Dizziness grade 1-2, 35%
400 mg 2 times / day multiple, oral (max)
Highest studied dose
Dose: 400 mg, 2 times / day
Route: oral
Route: multiple
Dose: 400 mg, 2 times / day
Sources: Page: p.1142
unhealthy, ADULT
n = 31
Health Status: unhealthy
Condition: Cardiac Failure Congestive
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Population Size: 31
Sources: Page: p.1142
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.
1980 Nov 20
Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors.
1987 Dec 1
Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter.
1992 Apr
Role of neutral endopeptidase in exercise-induced bronchoconstriction in asthmatic subjects.
1996 Aug
The effect of inhaled thiorphan on allergen-induced airway responses in asthmatic subjects.
1996 May
Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure.
2002 May
Mechanism of vasopeptidase inhibitor-induced plasma extravasation: comparison of omapatrilat and the novel neutral endopeptidase 24.11/angiotensin-converting enzyme inhibitor GW796406.
2005 Dec
Patents

Sample Use Guides

Mice: 300 mg/kg
Route of Administration: Intraperitoneal
In saturation binding studies in various mouse tissues [3H]-thiorphan exhibited an affinity (Kd value) of 0.46–0.77 nM, and the density of [3H]-thiorphan binding sites was well correlated with measured enkephalinase activity in a panel of 11 different mouse tissues.
Name Type Language
THIORPHAN
Common Name English
RACECADOTRIL IMPURITY B [EP IMPURITY]
Common Name English
DL-THIORPHAN
Common Name English
N-((RS)-2-BENZYL-3-MERCAPTOPROPANOYL)-GLYCINE
Systematic Name English
NSC-727676
Code English
GLYCINE, N-(2-(MERCAPTOMETHYL)-1-OXO-3-PHENYLPROPYL)-
Systematic Name English
(((2RS)-2-BENZYL-3-SULFANYLPROPANOYL)AMINO)ACETIC ACID
Systematic Name English
(±)-THIORPHAN
Common Name English
GLYCINE, N-(2-(MERCAPTOMETHYL)-1-OXO-3-PHENYLPROPYL)-, (+-)-
Systematic Name English
Code System Code Type Description
NSC
727676
Created by admin on Sat Dec 16 01:47:31 UTC 2023 , Edited by admin on Sat Dec 16 01:47:31 UTC 2023
PRIMARY
EPA CompTox
DTXSID70868412
Created by admin on Sat Dec 16 01:47:31 UTC 2023 , Edited by admin on Sat Dec 16 01:47:31 UTC 2023
PRIMARY
CAS
76721-89-6
Created by admin on Sat Dec 16 01:47:31 UTC 2023 , Edited by admin on Sat Dec 16 01:47:31 UTC 2023
PRIMARY
SMS_ID
100000085216
Created by admin on Sat Dec 16 01:47:31 UTC 2023 , Edited by admin on Sat Dec 16 01:47:31 UTC 2023
PRIMARY
MESH
D015244
Created by admin on Sat Dec 16 01:47:31 UTC 2023 , Edited by admin on Sat Dec 16 01:47:31 UTC 2023
PRIMARY
EVMPD
SUB21843
Created by admin on Sat Dec 16 01:47:31 UTC 2023 , Edited by admin on Sat Dec 16 01:47:31 UTC 2023
PRIMARY
FDA UNII
B79L7B5X3Z
Created by admin on Sat Dec 16 01:47:31 UTC 2023 , Edited by admin on Sat Dec 16 01:47:31 UTC 2023
PRIMARY
DRUG BANK
DB08626
Created by admin on Sat Dec 16 01:47:31 UTC 2023 , Edited by admin on Sat Dec 16 01:47:31 UTC 2023
PRIMARY
WIKIPEDIA
THIORPHAN
Created by admin on Sat Dec 16 01:47:31 UTC 2023 , Edited by admin on Sat Dec 16 01:47:31 UTC 2023
PRIMARY
PUBCHEM
3132
Created by admin on Sat Dec 16 01:47:31 UTC 2023 , Edited by admin on Sat Dec 16 01:47:31 UTC 2023
PRIMARY